Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA panel votes in favor of approving AstraZeneca's gout drug

Saturday, October 24, 2015

An independent panel of advisers to the US Food and Drug Administration on Friday voted in favor of approving AstraZeneca Plcs gout drug All who backed the drug lesinurad qualified their vote by urging the FDA to ask AstraZeneca for studies after...

Merrimack Pharma's cancer drug wins FDA approval

Friday, October 23, 2015

The US Food and Drug Administration approved Merrimack Pharmaceutical Incs pancreatic cancer therapy Onivyde making it the companys first approved drug Onivyde when used in combination with chemotherapy drugs fluorouracil FU and leucovorin is intend...

Perrigo Makes Moves to Fend off Mylan, Including Buybacks, Job Cuts

Friday, October 23, 2015

Perrigo Co said Thursday that it would cut about of its workforce sell its vitamins business and repurchase up to billion in shares as the generic drug company continues to fend off a takeover by Mylan NV The actions we are announcing today to dri...

AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations

Friday, October 23, 2015

AstraZeneca and Eli Lilly and Company Lilly announced an extension to their existing immunooncology collaboration exploring novel combination therapies for the treatment of patients with solid tumours Under the terms of the expanded agreement AstraZ...

Shanxi Zhendong Pharma to acquire Kangyuan Pharma for 2.65 bln yuan

Friday, October 23, 2015

Shanxi Zhendong Pharmaceutical Co Ltd says plans to acquire kangyuan pharmaceutical for billion yuan million via cash share issue reuterscom

Novartis broadens cancer immune therapy pipeline with acquisition, licensing pacts

Wednesday, October 21, 2015

Novartis said it broadened its immunooncology pipeline with the acquisition of Admune Therapeutics and licensing agreements with Xoma and Palobiofarma Palobiofarma a Spanish biotech said separately it entered into a million licensing agreement with...

Swedish firm Recipharm buys majority stake in Nitin Lifesciences for Rs 671 crore

Wednesday, October 21, 2015

Swedish contract drug manufacturing firm Recipharm has acquired a equity stake in Nitin Lifesciences a privately held sterile injectables manufacturing firm for Rs crore The move to buy into the Indian firm will help Recipharm expand its emerging m...

AstraZeneca opens new $224 mln drug factory in Russia

Wednesday, October 21, 2015

AstraZeneca opened a new million drug manufacturing and packaging factory in Russia on Tuesday in a move Chief Executive Pascal Soriot said reinforced its longterm commitment to the country In the Britishbased group was one of the first multinatio...

Germany’s Boehringer denied patent on HIV drug

Wednesday, October 21, 2015

The Indian Patent Office has denied Germanys Boehringer Ingelheim a patent on its key HIV drug Nevirapine for a version sold as Viramune XR extended release yet again thwarting attempts by Big Pharma for exclusivity extension on their patented drugs...

Jubilant Life Sciences gets USFDA nod for migraine treatment drug

Tuesday, October 20, 2015

Jubilant Life Sciences today announced receipt of approval from the US health regulator for its generic version of Mercks acute migraine treatment medicine MaxaltMLT The company has received Abbreviated New Drug Application ANDA final approval from...